PCC Rokit (PCR) Q2 2026 earnings summary

Executive summary

• EBITDA rose by 51% year-over-year to 178.9 million PLN, with net profit up nearly tenfold to 79.3 million PLN for 1H 2026.

• All business segments improved EBITDA versus 1H 2025, with the Polyurethanes segment leading growth.

• The Group maintained resilience through diversified operations, broad product offerings, and a wide customer base.

Financial highlights

• Consolidated revenue was 944.5 million PLN, down 1.4% year-over-year, mainly due to lower sales in Chlorine Derivatives.

• EBITDA reached 178.9 million PLN (+51.3% y/y), net profit 79.3 million PLN (+861.6% y/y), and operating profit 103.0 million PLN (+162.8% y/y).

• Net cash from operations was 125.0 million PLN (+2.4% y/y), with net cash outflows from investing and financing activities.

• ROA improved to 3.3% (from 0.3%), ROE to 5.7% (from 0.6%), and EBITDA margin to 18.9% (from 12.3%).

Outlook and guidance

• The Group expects continued operational cash flow to cover investments and debt service.

• External factors such as geopolitical tensions, energy prices, and regulatory changes may impact future performance.